The Latin America, Middle East and Africa Amniocentesis Needle Market would witness market growth of 8.3% CAGR during the forecast period (2023-2030).
There is a growing emphasis on patient education and counseling throughout the prenatal testing. Genetic counselors play a crucial role in providing information, support, and guidance to expectant parents, helping them understand their testing options, interpret results, and make informed decisions about pregnancy management.
Regulatory agencies and healthcare organizations will continue to establish and enforce stringent quality standards, guidelines, and protocols for manufacturing, distributing, and using amniocentesis needles and related medical devices. Ensuring adherence to regulatory requirements and standard prenatal care and genetic testing procedures will be paramount to guarantee product quality, patient safety, and clinical effectiveness.
As per the ITA, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian Government continues to prioritize this sector. In 2023, healthcare and social development will account for $50.4 billion, or 16.96 percent of the budget. The Saudi Arabian government intends to allocate more than $65 billion towards advancing the nation's healthcare infrastructure as part of Vision 2030. Additionally, the initiative strives to enhance the proportion of private sector funding from 40 to 65 percent by 2030, with 290 hospitals and 2300 primary healthcare facilities being privatized in the process. Hence, the expanding healthcare sector in the region is propelling the market's growth.
The Brazil market dominated the LAMEA Amniocentesis Needle Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5196.8 Million by 2030. The Argentina market is showcasing a CAGR of 9.1% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.9% during (2023 - 2030).
Based on Procedure, the market is segmented into Amniocentesis Procedures, Fetal Blood Transfusion, Amnioreduction Procedures, Amnioinfusion Procedure, and Cordocentesis Procedure. Based on End-use, the market is segmented into Hospitals, Diagnostics centers, Clinics, and Others. Based on Type, the market is segmented into 100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
There is a growing emphasis on patient education and counseling throughout the prenatal testing. Genetic counselors play a crucial role in providing information, support, and guidance to expectant parents, helping them understand their testing options, interpret results, and make informed decisions about pregnancy management.
Regulatory agencies and healthcare organizations will continue to establish and enforce stringent quality standards, guidelines, and protocols for manufacturing, distributing, and using amniocentesis needles and related medical devices. Ensuring adherence to regulatory requirements and standard prenatal care and genetic testing procedures will be paramount to guarantee product quality, patient safety, and clinical effectiveness.
As per the ITA, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian Government continues to prioritize this sector. In 2023, healthcare and social development will account for $50.4 billion, or 16.96 percent of the budget. The Saudi Arabian government intends to allocate more than $65 billion towards advancing the nation's healthcare infrastructure as part of Vision 2030. Additionally, the initiative strives to enhance the proportion of private sector funding from 40 to 65 percent by 2030, with 290 hospitals and 2300 primary healthcare facilities being privatized in the process. Hence, the expanding healthcare sector in the region is propelling the market's growth.
The Brazil market dominated the LAMEA Amniocentesis Needle Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5196.8 Million by 2030. The Argentina market is showcasing a CAGR of 9.1% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.9% during (2023 - 2030).
Based on Procedure, the market is segmented into Amniocentesis Procedures, Fetal Blood Transfusion, Amnioreduction Procedures, Amnioinfusion Procedure, and Cordocentesis Procedure. Based on End-use, the market is segmented into Hospitals, Diagnostics centers, Clinics, and Others. Based on Type, the market is segmented into 100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- BIOPSYBELL S.R.L.
- Cook Medical, Inc. (Cook Group)
- Ri.Mos. Srl
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- Rocket Medical plc (Röko AB)
- Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
- Moller Medical GmbH (Centrotec SE)
- Becton, Dickinson and Company
Market Report Segmentation
By Procedure- Amniocentesis Procedures
- Fetal Blood Transfusion
- Amnioreduction Procedures
- Amnioinfusion Procedure
- Cordocentesis Procedure
- Hospitals
- Diagnostics centers
- Clinics
- Others
- 100 to 150 mm
- Larger Than 150 mm
- Smaller Than 100 mm
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Amniocentesis Needle Market, by Procedure
Chapter 5. LAMEA Amniocentesis Needle Market, by End-use
Chapter 6. LAMEA Amniocentesis Needle Market, by Type
Chapter 7. LAMEA Amniocentesis Needle Market, by Country
Chapter 8. Company Profiles
Companies Mentioned
- BIOPSYBELL S.R.L.
- Cook Medical, Inc. (Cook Group)
- Ri.Mos. Srl
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- Rocket Medical plc (Röko AB)
- Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
- Moller Medical GmbH (Centrotec SE)
- Becton, Dickinson and Company
Methodology
LOADING...
